The advance of<sup>211</sup>At labelled radiopharmaceuticals

TANG Jun  LIU Ning  YANG Yuanyou  JIN Jiannan

doi:null

您当前的位置：

首页 >

文章列表页 >

The advance of²¹¹At labelled radiopharmaceuticals

更新时间：2021-03-12

- The advance of²¹¹At labelled radiopharmaceuticals
- NUCLEAR TECHNIQUES Issue 11, (2002)
- 作者机构：
  
  1. 四川大学原子核科学技术研究所
  2. 辐射物理及技术教育部重点实验室,成都,610064
- 作者简介：
- 基金信息：
  
  国家自然科学基金资助项目 (2 96 0 10 0 4,2 0 1710 33)
- DOI：
  CLC： R817
- Published：01 November 2002
- 稿件说明：
移动端阅览
[1]唐军,刘宁,杨远友,金建南.~(211)At标记放射治疗药物进展[J].核技术,2002(11):973-979.

TANG Jun LIU Ning YANG Yuanyou JIN Jiannan. The advance of²¹¹At labelled radiopharmaceuticals[J]. Nuclear techniques, 2002, (11): 973-979.
[1]唐军,刘宁,杨远友,金建南.~(211)At标记放射治疗药物进展[J].核技术,2002(11):973-979. DOI：

TANG Jun LIU Ning YANG Yuanyou JIN Jiannan. The advance of²¹¹At labelled radiopharmaceuticals[J]. Nuclear techniques, 2002, (11): 973-979. DOI：

摘要

211At具有良好的放射生物学性质

是一种极有希望的肿瘤放射性治疗核素。本文在参考39篇论文的基础上

综述了2 11At标记放射治疗药物近年来取得的一些可喜进展。对2 11At标记放射治疗药物研究存在的问题、现状及临床应用前景也进行了探讨。

Abstract

At is a promising radioisotope for cancer therapy due to its favorable radiobiological characteristics. The progress of radiotherapeutic drugs labelled with 211At is reviewed based upon 39 references. Additionally

its present status

problems and prospect are also discussed.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

An incompatibility problem and solution of multimodal image-guided radiotherapy based on domestic equipment

Experimental study of radiotargeting-therapy with small molecular polypeptide in nude mice bearing lung adenocarcinoma

Estimation of second primary cancers risk based on the treatment planning system

Establishment and application of voxel-by-voxel-based objective dose in optimizing radiotherapy planning

Analysis of subjective variability in gross tumor volume (GTV) delineation during radiotherapy

Related Author

YIN Yunpeng

LUO Kelin

XIE Zhao

HU Jinyou

ZOU Lian

郭琳琅

李贵平

黄宝丹

Related Institution

Cancer Center, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital

南方医科大学南方医院

南方医科大学珠江医院

安徽省精确放疗工程技术研究中心

中国科学院等离子体物理研究所

AI问答

Address：2019 Jialuo Road, Jiading, Shanghai, China Postal code：201800
Tel：021-39194977 Email：LHB@sinap.ac.cn
Technical support is provided by Beijing Founder electronics co., LTD 沪ICP备05005479号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.
Total Visits：881003 Visits Today：530

⁰

The advance of211At labelled radiopharmaceuticals

DOI：

摘要

Abstract

关键词

Keywords

references

The advance of²¹¹At labelled radiopharmaceuticals